These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 9810172

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Liberski PP.
    Pol J Pathol; 1998; 49(4):267-71. PubMed ID: 10323080
    [Abstract] [Full Text] [Related]

  • 3. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C.
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial.
    Schober R, Bilzer T, Waha A, Reifenberger G, Wechsler W, von Deimling A, Wiestler OD, Westphal M, Kemshead JT, Vega F.
    Clin Neuropathol; 1995 Aug; 14(3):169-74. PubMed ID: 7671460
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP.
    Cancer Res; 1993 Jun 15; 53(12):2736-9. PubMed ID: 8504413
    [Abstract] [Full Text] [Related]

  • 11. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
    Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 15; 14(7):1774-83. PubMed ID: 16030116
    [Abstract] [Full Text] [Related]

  • 12. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway.
    Das A, Tan WL, Teo J, Smith DR.
    J Neurooncol; 2002 Nov 15; 60(2):117-25. PubMed ID: 12635658
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.
    Halatsch ME, Schmidt U, Unterberg A, Vougioukas VI.
    Anticancer Res; 2006 Nov 15; 26(6B):4191-4. PubMed ID: 17201132
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T, Hirato J, Nakazato Y.
    Neuropathology; 2008 Apr 15; 28(2):116-26. PubMed ID: 18021194
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.